BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Activin receptor-like kinase 2 (ALK2; ACVR1); activin A

November 5, 2015 8:00 AM UTC

Cell culture and mouse studies suggest antibodies against the ALK2 ligand activin A could help treat fibrodysplasia ossificans progressiva (FOP). In human cell-based assays, activin A induced signalin...